tiprankstipranks
Biofrontera Receives Nasdaq Non-Compliance Notice
PremiumCompany AnnouncementsBiofrontera Receives Nasdaq Non-Compliance Notice
1M ago
Biofrontera, Inc. Earnings Call: Growth Amid Challenges
Premium
Company Announcements
Biofrontera, Inc. Earnings Call: Growth Amid Challenges
1M ago
Biofrontera Inc. price target lowered to $2.75 from $7 at Benchmark
Premium
The Fly
Biofrontera Inc. price target lowered to $2.75 from $7 at Benchmark
1M ago
Biofrontera Inc. announces patent protection on Ameluz until 2043
PremiumThe FlyBiofrontera Inc. announces patent protection on Ameluz until 2043
2M ago
Biofrontera Faces Nasdaq Non-Compliance Notice
Premium
Company Announcements
Biofrontera Faces Nasdaq Non-Compliance Notice
2M ago
Is BFRI a Buy, Before Earnings?
Premium
Pre-Earnings
Is BFRI a Buy, Before Earnings?
2M ago
BFRI Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsBFRI Upcoming Earnings Report: What to Expect?
3M ago
Biofrontera completes patient enrollment in Phase 3 study of Ameluz
Premium
The Fly
Biofrontera completes patient enrollment in Phase 3 study of Ameluz
3M ago
Biofrontera Inc. files to sell 5.72M shares of common stock for holders
Premium
The Fly
Biofrontera Inc. files to sell 5.72M shares of common stock for holders
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100